HTGM News and Press, HTG Molecular Diagnostics Inc. From 12/12/22

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Evgeny Karandaev/ShutterStock.com Reborn Coffee (NASDAQ: REBN ) stock is heating up on Monday as investors take note of the California coffee company’s shares. With that comes heavy trading of REB...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Bukhta Yurii / Shutterstock.com Harpoon Therapeutics (NASDAQ: HARP ) stock is taking off on Monday following the release of updated results from its myeloma drug candidate. HPN217 is the company’s...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Shutterstock HTG Molecular Diagnostics (NASDAQ: HTGM ) stock is rocketing higher on Monday as investors prepare for a major event on Dec. 13 . That’s when the company will hold its HTG Therapeutics...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: oneinchpunch/Shutterstock.com We’re starting off the week with a look at the biggest pre-market stock movers for Monday! Moving stocks are upcoming meetings, clinical trial news, and more. Let’s ...

AMAM Stock Explodes & Shed Light On Cheap Low Float Stocks One of the exciting things about penny stocks is that they can break out big even if the stock market is down. On top of that, it doesn’t take any significant catalyst to spark a rally. Many catalysts that trigger a ret...

TUCSON, Ariz., Dec. 09, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling and advanced medicinal chemistry technology, today announced it will host its next HTG The...

TUCSON, Ariz., Dec. 06, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling and advanced medicinal chemistry technology, today announced there will be at least eight ...

HTG Molecular press release ( NASDAQ: HTGM ): Q3 GAAP EPS of -$0.41 beats by $0.13 . Revenue of $1.25M (-50.4% Y/Y) misses by $1.58M . For further details see: HTG Molecular GAAP EPS of -$0.41 beats by $0.13, revenue of $1.25M misses by $1.58M

TUCSON, Ariz., Nov. 10, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling and advanced medicinal chemistry technology, today reported financial results f...

TUCSON, Ariz. and PARIS, Oct. 26, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, and OmiCure ® , a leading European digital health com...